Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-20

Clinical Trial Update: Autoantibody Specificity and Response to IVIG in ITP

View source ↗

Summary

A completed Shandong University–sponsored trial evaluating autoantibody specificity in immune thrombocytopenia and the response to intravenous immunoglobulin (I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVIG (intravenous immunoglobulin)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia (ITP) | Status: COMPLETED